The Beauty Health Company reported strong Q4 2021 results with net sales increasing 105.6% compared to Q4 2020, driven by growth in the U.S., EMEA, and APAC regions. The company exceeded its guidance for the quarter and full year, navigating macro challenges and COVID-19 impacts.
Net sales increased 105.6% compared to Q4 2020, reaching $77.9 million.
Delivery Systems net sales increased to $42.7 million, with over 1,800 systems sold during the quarter.
Consumables net sales increased to $35.2 million compared to the same period last year.
Adjusted EBITDA increased to $8.5 million compared to $3.6 million in Q4 2020.
BeautyHealth is providing a fiscal 2022 net sales guidance range of $320.0 million to $330.0 million and adjusted EBITDA of approximately $50.0 million.
Visualization of income flow from segment revenue to net income